Stockreport

Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation [Seeking Alpha]

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF FDA issued breakthrough therapy designation for its LSD formulation, MM120 (lysergide d-tartrate). A coveted regulatory program for therapeutic candidates in the U.S., [Read more]